Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Ilika plc ( (GB:IKA) ).
Ilika plc has announced its half-year results, highlighting significant progress in the commercialization of its Stereax and Goliath battery lines. The Stereax batteries, produced in partnership with Cirtec, are set to generate revenues in 2025, targeting medical device applications. The Goliath line, aimed at electric vehicles, has achieved key milestones, including a fivefold energy capacity increase since the release of its prototypes. Ilika’s advancements position the company to capitalize on commercial opportunities in medical and automotive markets, supported by government grants and increased industrial partnerships.
More about Ilika plc
Ilika plc is a company specializing in the development and commercialization of solid-state batteries using ceramic-based lithium-ion technology. The company focuses on creating batteries for markets that cannot be addressed with conventional batteries due to safety, charge rates, energy density, and life limits. Ilika’s two main product lines are Stereax batteries, designed for medical implants and industrial wireless sensors, and Goliath batteries for electric vehicles and cordless appliances.
YTD Price Performance: -4.65%
Average Trading Volume: 361,690
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £34.3M
For an in-depth examination of IKA stock, go to TipRanks’ Stock Analysis page.
